FDA Adverse Event Injury Summary report: N

PROLIFT PELVIC FLOOR REPAIR

MDR report key: 3032897 · Received April 3, 2013

Report

Report Number
2210968-2013-03142
Event Type
Injury
Date Received
April 3, 2013
Report Date
March 14, 2013
Manufacturer
ETHICON, INC.
Product Code
OTP
PMA / PMN Number
K013718
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

(B)(4). IT WAS REPORTED THAT FOLLOWING INSERTION THE PATIENT EXPERIENCED PAIN, EROSION, EXTRUSION, URINARY PROBLEMS, FISTULAE, ORGAN PERFORATION, BLEEDING, RECURRENCE, DYSPAREUNIA AND VAGINAL SCARRING. IT WAS REPORTED THAT PATIENT EXPERIENCED DYSPAREUNIA, CONTRACTURE AND FIBROSIS AND UNDERWENT CYSTOSCOPY, RIGHT URETAL STENT PLACEMENT, EXCISION OF ANCHOR ARMS FOR THE ANTERIOR MESH AND LYSIS OF ADHESIONS ON (B)(6) 2010. (B)(4).

Additional Manufacturer Narrative · 1

(B)(4). NO CONCLUSION CAN BE DRAWN AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE OBTAINED, A SUPPLEMENTAL 3500A FORM WILL BE SUBMITTED ACCORDINGLY.

Additional Manufacturer Narrative · 1

(B)(4). IT WAS REPORTED THAT THE PATIENT UNDERWENT A GYNECOLOGICAL PROCEDURE ON (B)(6) 2008 AND MESH WAS IMPLANTED CONCURRENTLY WITH CYSTOSCOPY DUE TO STRESS URINARY INCONTINENCE AND CYSTOCELE. IN ADDITION, A REVIEW OF THE BATCH MANUFACTURING RECORDS WAS CONDUCTED AND THE BATCH MET ALL FINISHED GOODS RELEASE CRITERIA.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT UNDERWENT SURGICAL PROCEDURES ON (B)(6) 2008 AND MESH WAS IMPLANTED. THE PATIENT EXPERIENCED PAIN, EROSION OF HER INTERNAL BODILY TISSUE AND OTHER INJURIES FOLLOWING THE PROCEDURE. IT WAS REPORTED THAT THE PATIENT HAS UNDERGONE MULTIPLE SURGERIES AND REVISIONARY PROCEDURES. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
137187 PROLIFT PELVIC FLOOR REPAIR MESH, SURGICAL, POLYMERIC OTP ETHICON, INC. NA 3100637

Patients

Seq Age Sex Outcome Treatment
1 39 YR Required Intervention